About us

ADP works to ensure that people in low- and middle-income countries have access to life-saving health technologies – medicines, vaccines and diagnostic tools – with an emphasis on those technologies that address tuberculosis, malaria and neglected tropical diseases.

The partners

ADP brings together the United Nations Development Programme (UNDP), the World Health Organization (WHO), the Special Programme for Research and Training in Tropical Diseases (TDR) and PATH in a unique partnership that helps identify and strengthen capacity gaps in low- and middle-income countries in an innovative and integrated way.

Strengthening national health systems

In line with the overarching approach of the 2030 Agenda for Sustainable Development, ADP adopts a systemic and integrated perspective towards health system strengthening, aimed at the interlinked targets of eliminating communicable and infectious diseases and achieving real progress towards universal health coverage.

Supporting national responses to COVID-19

The COVID-19 pandemic has highlighted the critical importance of ensuring equitable access to health services, as well as increasing availability of medicines, vaccines and diagnostic tools in response to established and emerging health threats.

Regional, global and
South-South cooperation

Focusing on common challenges across different health systems, ADP leverages the experiences and expertise of its network of stakeholders to deliver both policy lessons and technical solutions.

Focus countries

ADP collaborates with stakeholders in a number of focus countries – Bhutan, Burkina Faso, Ghana, India, Indonesia, Malawi, Senegal, United Republic of Tanzania and Thailand
– to implement a range of capacity-strengthening interventions, which are in line with the ADP strategic approach of leveraging the expertise of its four core partners and working across sectors to help strengthen and harmonize policies, regulations and systems, as well as build the capacities of key people and institutions.

Uniting Efforts

The global response to the COVID-19 pandemic has highlighted how close collaboration among multiple stakeholders can overcome major hurdles to the development, approval and delivery of new medicines, vaccines and diagnostic tools. But opportunities for such intense collaboration are rare, and access to new health technologies remains uneven.

Knowledge products

ADP knowledge products advance learning and contribute to improved policies, programmes and practices, as well as demonstrate human impact on the ground.

TDR Implementation research toolkit

This toolkit is designed to help teams conduct implementation research projects through a standard process to ensure reliable, high-quality results.

COVID-19 diagnostics procurement resource

An interactive tool to support procurement decisions by aggregating and streamlining publicly available information about the technical specifications, regulatory status and supply of COVID-19 diagnostic tests.

A pipeline analysis of new products for malaria, tuberculosis and neglected tropical diseases

This working paper provides a comprehensive survey of new medicines, diagnostics and vaccines for malaria, TB and selected NTDs, that are currently in the pipeline for market entry by 2020.

Digital Health for Development Hub

A one-stop shop with technical, advisory and partnership support for scaling up digital health solutions.

COVID-19 Diagnostics Procurement Resource

About this resource

Large-scale testing and contact tracing are central to efforts to control the COVID-19 pandemic. Such efforts rely on diagnostic tests that can rapidly, accurately and reliably detect SARS-CoV-2. However, with over 1,000 COVID-19 diagnostic tests currently in development or on the market, understanding test quality, performance and availability at the global and country level is extremely challenging.

This COVID-19 Diagnostic Procurement Resource, developed in a collaboration between PATH and ADP, provides a focused view of data of particular interest to procurement teams researching appropriate COVID-19 diagnostic tests.

Diagnostic tests can be filtered by country-specific regulatory status and key test specifications to identify products that meet procurement needs, and offer easy access to additional information on available products that meet these criteria.

This COVID-19 Diagnostics Procurement Resource is one of several COVID-19 Diagnostics Dashboards developed by a multi-disciplinary team at PATH to consolidate publicly available market intelligence to support data-driven procurement and purchasing decisions. These additional dashboards are listed in the “Making sense of COVID-19 diagnostics” section.

Preparing data...

Assumptions

All data represents publicly available information, compiled from product IFUs, inserts, and webpages, regulatory authority websites, and outreach to manufacturers. Scope of data collected is subject to change as additional products are added to the resource. Global and private distributor information is also based on publicly available information, with any available contact information included in the exportable file available for download. Pricing information is indicative only.

Data will be updated each quarter. To be notified about updates to the PATH COVID-19 diagnostic dashboards, including this procurement platform, please email DxCOVID@path.org.

Disclaimer

The information contained on this website is for general information purposes only and does not in any way imply an endorsement, certification, warranty of fitness, or recommendation of any company or product for any purpose. The information is provided by PATH and ADP, and while every effort is made to ensure the data quality, the data is provided "as is," as we cannot warrant the accuracy, reliability, suitability, or completeness of the information for any purpose.

If you are a developer or manufacturer of a COVID-19 diagnostic test and would like to update your product information, please reach out to DxCOVID@path.org.

Learn more about PATH’s diagnostics program.